Protalix BioTherapeutics, Inc. reports

Company identity 1 identity field
Location
Hackensack, NJ
SEC filing record 1 source field
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 51-75 of 671 matching filings.

Per page
25
Current page
3
424B5 File 333-264394

424B5

Filing date
17 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
05 Nov 2024
Reporting date
23 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A filing

Filing date
25 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Sep 2024
Reporting date
23 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Sep 2024
Reporting date
23 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-280644

FORM S-8

Filing date
01 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-33357

ARS

Filing date
17 May 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
17 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A

Filing date
29 Apr 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2024
Reporting date
01 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .